JAZZ PHARMACEUTICALS RESEARCH UK LIMITED v. TEVA PHARMACEUTICALS, INC. et al
Case Number:
2:23-cv-00018
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
- Carella Byrne
- Carlton Fields
- Cozen O'Connor
- Daignault Iyer
- Fox Rothschild
- Goodwin Procter
- Hill Wallack
- Lerner David
- Midlige Richter
- Polsinelli PC
- Quinn Emanuel
- Rivkin Radler
- Saul Ewing
- Stone Conroy LLC
- Taft Stettinius
- Walsh Pizzi
Companies
- Alkem Laboratories Ltd.
- Altaris Capital Partners LLC
- Apotex Inc.
- Cipla Ltd.
- Jazz Pharmaceuticals Inc.
- Lupin Ltd.
- Taro Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
Sectors & Industries:
-
February 10, 2025
Jazz Pharma Drops Last Defendant From Epidiolex Patent Suit
Jazz Pharmaceuticals Inc. has reached an agreement to dismiss all claims and counterclaims with the last remaining defendant in its consolidated lawsuits over patents covering its epilepsy treatment Epidiolex, according to a filing from the company in New Jersey federal court.
-
January 11, 2024
NJ Judge Not Convinced Epidiolex Seller Lied To USPTO
A New Jersey federal judge on Thursday dismissed allegations that 19 Jazz Pharmaceuticals patents covering its epilepsy treatment Epidiolex aren't enforceable, saying there's no evidence that the company lied to the patent office to dodge higher fees.
-
July 18, 2023
CBD Co. Wants Counterclaims Nixed In Epidiolex Patent Row
British pharmaceutical firm GW Pharmaceuticals has urged a New Jersey federal judge to toss counterclaims lodged by InvaGen Pharmaceuticals in a patent dispute regarding GW's flagship CBD-derived epilepsy treatment Epidiolex.
-
January 05, 2023
CBD Drug Co. Alleges Teva, Others Violated Patents
British pharmaceutical firm GW Pharmaceuticals has accused a dozen drug manufacturers, including Teva Pharmaceuticals, of violating its patents when they sought approval to sell generic versions of the company's flagship CBD-derived epilepsy treatment Epidiolex.